-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on GeneDx Holdings, Raises Price Target to $83

Benzinga·10/01/2026 13:46:24
语音播报
Guggenheim analyst Subbu Nambi maintains GeneDx Holdings (NASDAQ:WGS) with a Buy and raises the price target from $74 to $83.